NorthWest Biotherapeutics Inc (NWBO)

[Flexroy]

I read 10 mil of series C. Am I wrong?

The Series C Certificate of Designations, effective as of July 20, 2022, establishes the rights, preferences and privileges of the 10,000,000 shares of the Company?s Series C Preferred Stock, par value $0.001 per share (the ?Series C Shares?).

and...


Our Certificate of Incorporation authorizes us to issue up to 100,000,000 shares of preferred stock, of which 885,155 shares are outstanding.


Our board of directors may, without stockholder approval, issue up to 100,000,000 shares of preferred stock in one or more series